The final determination on new Section 301 tariffs largely aligns with proposed rules, apart from hikes on some medical supplies, and leaves domestic manufacturing equipment inputs ineligible for exclusions.
A proposed de minimis rule would prohibit duty-free treatment for products covered by sections 201, 301, or 232 tariffs and is expected to shake up congressional debate on the issue.
Discussions on China’s PNTR status are evolving toward a more intricate approach, though some continue to call for a complete revocation.